PhilipOPonceMD(He/Him)

HIV/AIDS Medicine, Transplant/Immunocompromised States, STD Medicine

Assistant Director/Medical Monitor Pneumococcal Vaccines Pfizer VRD

Dr. Ponce is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2016 - 2018
University of California (San Francisco)Residency, Internal Medicine, 2006 - 2009
Perelman School of Medicine at the University of PennsylvaniaClass of 2006

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

PubMed

1153 citations
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
Andre C. Kalil, Thomas F. Patterson, Aneesh K. Mehta, Kay M. Tomashek, Cameron R. Wolfe
The New England Journal of Medicine. 2021-03-04
96 citations
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...
Andre C. Kalil, Aneesh K. Mehta, Thomas F Patterson, Nathaniel B. Erdmann, Carlos A. Gomez
The Lancet. Respiratory Medicine. 2021-10-18
61 citations
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi
The Lancet. Respiratory Medicine. 2022-09-01

The Future of MonkeypoxNovember 28th, 2022
‘Desperate Need’: San Antonio Doctors Use COVID-Positive Donor Organs for Kidney, Liver TransplantsSeptember 2nd, 2022